CAS: 956590-23-1 - UNBS5162
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | UNBS5162 REF: IN-DA01DX4WCAS: 956590-23-1 | 98% | To inquire | Wed 12 Feb 25 |
 | UNBS5162 REF: TM-T2477CAS: 956590-23-1 | 98.37% - 99.97% | 39.00 €~1,291.00 € | Wed 19 Feb 25 |
 | UNBS5162 REF: 3D-GNB59023CAS: 956590-23-1 | Min. 95% | To inquire | Wed 26 Mar 25 |
Ref: IN-DA01DX4W
| 10mg | 161.00 € | ||
| 25mg | 228.00 € | ||
| 50mg | 514.00 € |
Estimated delivery in United States, on Wednesday 12 Feb 2025
UNBS5162
CAS:956590-23-1
UNBS5162 (UNBS-5162) is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
Formula:
C17H18N4O3
Purity:
98.37% - 99.97%
Color and Shape:
Solid
Molecular weight:
326.35
Ref: TM-T2477
| 1mg | 39.00 € | ||
| 5mg | 81.00 € | ||
| 10mg | 115.00 € | ||
| 25mg | 213.00 € | ||
| 50mg | 336.00 € | ||
| 100mg | 534.00 € | ||
| 200mg | 778.00 € | ||
| 1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Wednesday 19 Feb 2025
UNBS5162
CAS:956590-23-1
UNBS5162 is a naphthalimide that has been shown to be dose-limiting in the treatment of …
Formula:
C17H18N4O3
Purity:
Min. 95%
Molecular weight:
326.35 g/mol
Ref: 3D-GNB59023
| 50mg | 1,016.00 € | ||
| 100mg | 1,413.00 € |
Estimated delivery in United States, on Wednesday 26 Mar 2025
